|Posted:||December 10, 2018 03:22 PM|
|From:||Senator Bob Mensch|
|To:||All Senate members|
|Subject:||Specialty Tier Drug Co-payment Caps|
|In the near future, I will be reintroducing legislation that will cap co-payments for the out of pocket cost of specialty tier drugs.
Many surrounding states have already taken steps to protect those that suffer from rare conditions such as hemophilia, hepatitis, multiple sclerosis, lupus, some cancers, rheumatoid arthritis and other serious chronic health issues from the high out of pocket costs.
As of right now, the Affordable Care Act individual’s maximum out of pocket costs are $6,600 per year for self only coverage and $13,200 for other than self-only coverage. I believe this is incredibly high. My legislation would limit a patients cost to $100 per 30 day supply of any single specialty tier drug and not exceed $200 per month.
Thus far, eighteen states, including Pennsylvania, have introduced or enacted legislation to help people with the cost of these life-saving drugs. They are as follows:
I hope you will join me in co-sponsoring this legislation to cap the highest co-payments for medications and to more evenly distribute the pharmacy costs between enrollees and insurers.
If you have any questions please contact Mark Fetzko at 717-787-3110.
Introduced as SB484